Detalhe da pesquisa
1.
Family Matters: Germline Testing in Thoracic Cancers.
Am Soc Clin Oncol Educ Book
; 43: e389956, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167572
2.
BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms.
Oncogene
; 42(8): 572-585, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550359
3.
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
BMJ Open
; 13(11): e073120, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993149
4.
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance.
Cancer Res
; 82(24): 4571-4585, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353752
5.
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
J Thorac Oncol
; 17(7): 873-889, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462085
6.
Precision Therapy for Mesothelioma: Feasibility and New Opportunities.
Cancers (Basel)
; 13(10)2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067960
7.
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nat Commun
; 12(1): 1751, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741915
8.
CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM.
Blood Adv
; 2(15): 1869-1881, 2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082430
9.
Accelerating innovations in systemic therapy for pleural mesothelioma.
Nat Cancer
; 3(8): 902-904, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999308
10.
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nat Commun
; 12(1): 3569, 2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099722